Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (12)
P 3 (1)
P 4 (1)

Trial Status

Recruiting7
Unknown5
Active Not Recruiting5
Not Yet Recruiting3
Completed2
Enrolling By Invitation1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07520591Not Yet Recruiting

Valvosoft Outcomes Registry for Real-World Evidence

NCT05751577Not ApplicableActive Not RecruitingPrimary

TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial

NCT06596460Not ApplicableRecruitingPrimary

A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI)

NCT05714293Not ApplicableEnrolling By Invitation

CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.

NCT05172960Not ApplicableActive Not RecruitingPrimary

ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

NCT05168826Active Not RecruitingPrimary

China S3 PMS: SAPIEN 3 China Post Market Registry Study

NCT05714579Not ApplicableTerminatedPrimary

Predictive Value of Pre-TAVI Infrahissian Conduction Time in the Occurrence of Complete Atrioventricular Block

NCT06818110Not ApplicableActive Not RecruitingPrimary

The CardioFit Trial: Exercise Training Before Aortic Valve Surgery

NCT06377449Not ApplicableRecruiting

Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients

NCT06508866RecruitingPrimary

Timing And Typology of ConducTIon disturbanCes During TAVI

NCT03042104Not ApplicableActive Not Recruiting

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

NCT03003299Not ApplicableRecruiting

PARTNER 3 Trial - Aortic Valve-in-Valve

NCT06196177Phase 4Unknown

Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure

NCT05989074Not ApplicableUnknownPrimary

All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

NCT06129799RecruitingPrimary

Exercise CMR in (p)LF-LG AS

NCT06066632Unknown

Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study)

NCT06043180Not Yet RecruitingPrimary

Outcome Prediction in Patients With Aortic Stenosis After TAVI

NCT05813353Completed

Pre- and Post TAVI Cognitive Functioning and Intraoperative Carotid Flow Measurements

NCT05536310Not Yet Recruiting

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

NCT04976062Unknown

NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation

Scroll to load more

Research Network

Activity Timeline